Gallium-68
Ga-68 · Gallium, Z = 31, A = 68
Gallium-68 (Ga-68) carries 1.51e+18 Bq/g, or 4.09e+7 Ci/g: a gigabecquerel is 661 pg, no weighable quantity at all. It decays by positron emission and some electron capture with a half-life of 67.71 minutes, which leaves 4.0e-5% of today's activity after a day and 1.5e-43% after a week.
An air kerma rate constant of 0.129 mGy·m²/(GBq·h) is 1.7× Cs-137 and 2.4× less than Co-60, and 16 of 96 among the photon emitters carried here.
Halving the air kerma rate calls for 4.01 mm of lead, or 10.7 mm of steel where lead is unwelcome, and a factor of ten calls for 13.6 mm of lead — sheet thicknesses that a glovebox or a transport container can carry. Reaching 20 µSv/h from 1 GBq at a metre takes 10.9 mm of lead.
Ga-68 ligand selection and radiochemical control in PET
Ga-68 supplies the positron signal in PET tracers that target somatostatin receptors or prostate-specific membrane antigen. The isotope does not determine which tissue is highlighted: that depends on the molecule carrying it. Gallium-labelled dotatate binds somatostatin receptors and is used to locate receptor-positive neuroendocrine tumours. Gozetotide targets prostate-specific membrane antigen instead, supporting prostate cancer staging, investigation of suspected recurrence and assessment for certain targeted treatments. These are distinct medicines with different biological interpretations, even though the radioactive atom is the same.
Preparation of a Ga-68 medicine therefore involves more than measuring activity. The dotatate kit starts without radioactivity and is combined with gallium chloride from an approved generator. Labelling and buffering produce the injectable preparation, after which appearance, acidity and labelling efficiency are checked. Thin-layer chromatography separates labelled dotatate from other gallium species. A satisfactory activity reading alone cannot establish that the gallium is attached to the intended molecule. Radiochemical quality is what connects the detected radiation with the receptor-targeting behaviour expected from the medicine.
The nuclear signal remains common to these preparations. Ga-68 reaches Zn-68 through positron emission and electron capture; annihilation of the emitted positron supplies the photons on which PET detection relies. Less prominent nuclear gamma emissions accompany some decays. Consequently, a radionuclide spectrum can establish physical identity without establishing pharmaceutical identity. The distinction also matters when interpreting uptake: dotatate can accumulate in receptor-bearing normal tissues and in conditions other than neuroendocrine cancer. Its prescribing information specifically identifies physiological variants and other causes of uptake that can complicate image interpretation.
Generators are an important supply route, but Ga-68 is not restricted to generator production. The IAEA describes direct cyclotron production and the development of associated radiopharmaceuticals, broadening the available manufacturing routes. This does not make every gallium chloride preparation interchangeable with every kit: the relevant product specifications still govern preparation. For gozetotide imaging, the EMA describes use in specialised nuclear medicine facilities with trained staff and provision of educational material for interpretation. Both the supply chain and the clinical reading thus depend on the particular radiopharmaceutical, beyond the isotope's decay characteristics.
- LNHB / DDEP, Recommended nuclear data tables: Ga-68
- NETSPOT prescribing information, DailyMed, preparation, quality control and image interpretation
- European Medicines Agency, Locametz EPAR overview and therapeutic indication
- IAEA, Radioisotope Production and Radiation Technology, Annual Report 2020, cyclotron-based gallium-68
Half-life, specific activity and dose rate
| Half-life | 67.71 minutes (4063 s) |
| Decay mode | positron emission and some electron capture |
| Specific activity | 1.51e+18 Bq/g (4.09e+7 Ci/g) |
| Air kerma rate constant Γ (δ = 20 keV) | 0.129 mGy·m²/(GBq·h) |
| Dose rate, 1 GBq at 1 m | 0.129 mGy/h |
| Dose rate, 1 Ci at 1 m | 4.76 mGy/h |
| Kerma-weighted mean photon energy | 534.6 keV |
511 keV carries 96% of the dose rate
4 further lines below the 20 keV cutoff, the highest at 9.61 keV and 4.92% emission probability in all, are excluded here and from Γ. Probability and dose share.
| Energy (keV) | Emission probability (%) | Share of dose rate (%) |
|---|---|---|
| 511.00 | 177.82052 | 96.15 |
| 1077.34 | 3.22 | 3.40 |
| 1883.16 | 0.13653 | 0.22 |
| 1261.08 | 0.09435 | 0.11 |
| 805.83 | 0.09402 | 0.08 |
| 578.52 | 0.03349 | 0.02 |
| 1744.42 | 0.0095 | 0.01 |
| 2338.44 | 0.00113 | 0.00 |
4.01 mm of lead halves this spectrum
Solved numerically across all 8 lines, narrow beam. Why not one representative energy.
| Material | HVL (mm) | TVL (mm) | TVL / HVL |
|---|---|---|---|
| lead | 4.01 | 13.6 | 3.39 |
| tungsten | 2.75 | 9.28 | 3.38 |
| iron | 10.7 | 35.8 | 3.34 |
| copper | 9.49 | 31.7 | 3.34 |
| concrete | 34.6 | 115 | 3.33 |
| water | 73.2 | 244 | 3.33 |
| aluminum | 31.1 | 104 | 3.33 |
A single energy would give 3.32. Spectrum and attenuation ratios.
Activity over the first hours
Ten half-lives is 11.3 hours, so the activity moves measurably while a count is running: every figure has to carry the time it was referred to. The mean life 1/λ is 1.63 hours.
| Elapsed | Fraction remaining |
|---|---|
| 1 half-life | 50.0 % |
| 2 half-lives | 25.0 % |
| 5 half-lives | 3.13 % |
| 10 half-lives | 0.0977 % |
| Time to fall to 10 % of today's activity | 3.75 hours |
| Time to fall to 1 % | 7.50 hours |
| Time to fall to 0.1 % | 11.2 hours |
Limits of these dose rates
- Air kerma, 1 µGy counted as 1 µSv — not H*(10).
- Model limits and internal dose.
Gamma and decay calculators for Ga-68
Other Gallium nuclides: Ga-67
Computed from the IAEA Nuclear Data Section — Livechart API (ENSDF) and the NIST X-Ray Mass Attenuation Coefficients. Derivations and citations.